BACKGROUND: The eastern equine encephalitis (EEE) and Venezuelan equine encephalitis (VEE) viruses are pathogens that infect humans and horses in the Americas. Outbreaks of neurologic disease in humans and horses were reported in Panama from May through early August 2010. METHODS: We performed antibody assays and tests to detect viral RNA and isolate the viruses in serum samples from hospitalized patients. Additional cases were identified with enhanced surveillance. RESULTS: A total of 19 patients were hospitalized for encephalitis. Among them, 7 had confirmed EEE, 3 had VEE, and 1 was infected with both viruses; 3 patients died, 1 of whom had confirmed VEE. The clinical findings for patients with EEE included brain lesions, seizures that evolved to status epilepticus, and neurologic sequelae. An additional 99 suspected or probable cases of alphavirus infection were detected during active surveillance. In total, 13 cases were confirmed as EEE, along with 11 cases of VEE and 1 case of dual infection. A total of 50 cases in horses were confirmed as EEE and 8 as VEE; mixed etiologic factors were associated with 11 cases in horses. Phylogenetic analyses of isolates from 2 cases of equine infection with the EEE virus and 1 case of human infection with the VEE virus indicated that the viruses were of enzootic lineages previously identified in Panama rather than new introductions. CONCLUSIONS: Cases of EEE in humans in Latin America may be the result of ecologic changes that increased human contact with enzootic transmission cycles, genetic changes in EEE viral strains that resulted in increased human virulence, or an altered host range. (Funded by the National Institutes of Health and the Secretaría Nacional de Ciencia, Tecnología e Innovación, Panama.).
BACKGROUND: The eastern equine encephalitis (EEE) and Venezuelan equine encephalitis (VEE) viruses are pathogens that infect humans and horses in the Americas. Outbreaks of neurologic disease in humans and horses were reported in Panama from May through early August 2010. METHODS: We performed antibody assays and tests to detect viral RNA and isolate the viruses in serum samples from hospitalized patients. Additional cases were identified with enhanced surveillance. RESULTS: A total of 19 patients were hospitalized for encephalitis. Among them, 7 had confirmed EEE, 3 had VEE, and 1 was infected with both viruses; 3 patients died, 1 of whom had confirmed VEE. The clinical findings for patients with EEE included brain lesions, seizures that evolved to status epilepticus, and neurologic sequelae. An additional 99 suspected or probable cases of alphavirus infection were detected during active surveillance. In total, 13 cases were confirmed as EEE, along with 11 cases of VEE and 1 case of dual infection. A total of 50 cases in horses were confirmed as EEE and 8 as VEE; mixed etiologic factors were associated with 11 cases in horses. Phylogenetic analyses of isolates from 2 cases of equine infection with the EEE virus and 1 case of humaninfection with the VEE virus indicated that the viruses were of enzootic lineages previously identified in Panama rather than new introductions. CONCLUSIONS: Cases of EEE in humans in Latin America may be the result of ecologic changes that increased human contact with enzootic transmission cycles, genetic changes in EEE viral strains that resulted in increased human virulence, or an altered host range. (Funded by the National Institutes of Health and the Secretaría Nacional de Ciencia, Tecnología e Innovación, Panama.).
Authors: Aaron C Brault; Ann M Powers; Diana Ortiz; Jose G Estrada-Franco; Roberto Navarro-Lopez; Scott C Weaver Journal: Proc Natl Acad Sci U S A Date: 2004-07-26 Impact factor: 11.205
Authors: Nicole C Arrigo; A Paige Adams; Douglas M Watts; Patrick C Newman; Scott C Weaver Journal: Emerg Infect Dis Date: 2010-09 Impact factor: 6.883
Authors: Erica L Beatman; Aaron Massey; Katherine D Shives; Kristina S Burrack; Mastooreh Chamanian; Thomas E Morrison; J David Beckham Journal: J Virol Date: 2015-12-30 Impact factor: 5.103
Authors: Kathia Luciani; Iván Abadía; Alex O Martínez-Torres; Julio Cisneros; Ilka Guerra; Mariana García; Dora Estripeaut; Jean-Paul Carrera Journal: Am J Trop Med Hyg Date: 2015-04-13 Impact factor: 2.345
Authors: Jean-Paul Carrera; Karoun H Bagamian; Amelia P Travassos da Rosa; Eryu Wang; Davis Beltran; Nathan D Gundaker; Blas Armien; Gianfranco Arroyo; Néstor Sosa; Juan Miguel Pascale; Anayansi Valderrama; Robert B Tesh; Amy Y Vittor; Scott C Weaver Journal: Am J Trop Med Hyg Date: 2018-05-03 Impact factor: 2.345
Authors: Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton Journal: Am J Trop Med Hyg Date: 2014-05-19 Impact factor: 2.345
Authors: Colleen B Jonsson; Xufeng Cao; Jasper Lee; Jon D Gabbard; Yong-Kyu Chu; Elizabeth A Fitzpatrick; Justin Julander; Dong-Hoon Chung; Jennifer Stabenow; Jennifer E Golden Journal: Antiviral Res Date: 2019-04-07 Impact factor: 5.970
Authors: Scott J Barraza; Philip C Delekta; Janice A Sindac; Craig J Dobry; Jianming Xiang; Richard F Keep; David J Miller; Scott D Larsen Journal: Bioorg Med Chem Date: 2015-02-11 Impact factor: 3.641
Authors: Jocelyn G Pérez; Jean-Paul Carrera; Emmanuel Serrano; Yaneth Pittí; Jorge L Maguiña; Gregorio Mentaberre; Andrés G Lescano; Anayansi Valderrama; Pedro Mayor Journal: Am J Trop Med Hyg Date: 2019-12 Impact factor: 2.345
Authors: Jean-Paul Carrera; Hilda Guzman; Davis Beltrán; Yamilka Díaz; Sandra López-Vergès; Rolando Torres-Cosme; Vsevolod Popov; Steven G Widen; Thomas G Wood; Scott C Weaver; Lorenzo Cáceres-Carrera; Nikos Vasilakis; Robert B Tesh Journal: Am J Trop Med Hyg Date: 2015-08-24 Impact factor: 2.345
Authors: Yi Tan; Tommy Tsan-Yuk Lam; Lea A Heberlein-Larson; Sandra C Smole; Albert J Auguste; Scott Hennigan; Rebecca A Halpin; Nadia Fedorova; Vinita Puri; Timothy B Stockwell; Meghan H Shilts; Theodore Andreadis; Philip M Armstrong; Robert B Tesh; Scott C Weaver; Thomas R Unnasch; Alexander T Ciota; Laura D Kramer; Suman R Das Journal: J Virol Date: 2018-05-29 Impact factor: 5.103